On February 1st, the official website of the US Food and Drug Administration (FDA) released a statement regarding warning letters sent to 14 online retailers. These letters accuse the retailers of selling unauthorized e-cigarette products. The warning pertains to disposable e-cigarette products under brands such as Elf Bar/EB Design, Lava Plus, Funky Republic/Funky Lands, Lost Mary, Cali Bars, Cali Plus, and Kangvape.
These warnings are based on continuous monitoring of multiple surveillance systems by the FDA, with the aim of identifying products that are popular or appealing among young people.
According to the National Youth Tobacco Survey of 2023, over 50% of teenagers are using the disposable e-cigarette brand Elf Bar. It is understood that in 2023, the manufacturer of Elf Bar started promoting the product under the name "EB Design".
Furthermore, the FDA has identified Lava Plus, Funky Republic/Funky Lands, Kangvape, Cali, and Breeze among the popular or appealing brands for young people, based on a review of retail sales data and internal surveys.
Retailers who have received these warning letters would be in violation of the Federal Food, Drug, and Cosmetic Act if they sell or distribute e-cigarette products in the United States without FDA authorization. The recipients of the warning letters have 15 working days to respond and must provide details of the actions they will take to correct the non-compliant behavior and prevent similar violations from occurring in the future. Failure to promptly rectify these violations could result in additional actions by the FDA, such as injunctions, seizures, and/or civil fines.
This series of warning letters represents the latest initiative by the FDA in collaboration with retailers to address the unauthorized marketing and sale of e-cigarettes targeting young people. As of January 30, 2024, the FDA has issued warning letters and 88 civil money penalty (CMP) notices to over 440 retailers selling illegal e-cigarettes, encompassing physical retail stores across the country.
As of now, the FDA has authorized 23 e-cigarette devices and tobacco-flavored e-cigarette products. For retailers looking for information on legally selling e-cigarettes, the FDA provides printable flyers in addition to the authorized product list on their website. Additionally, the FDA is developing a searchable public database that will include all tobacco products that have received marketing orders from the FDA.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
